Ultragenyx Pharmaceutical... (RARE)
35.37
1.53 (4.52%)
At close: Apr 02, 2025, 3:59 PM
34.29
-3.05%
After-hours: Apr 02, 2025, 05:11 PM EDT
Ultragenyx Pharmaceutical Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -6.69 | -5.8 | -4.58 | -12.56 | -45.15 | -6 | -10.95 | -6.52 | -11.32 | -28.34 | -21.1 | -35.01 | -59.65 | -142.27 |
| PEG Ratio | 0.28 | 0.31 | -0.09 | -0.11 | 0.79 | -0.08 | 0.25 | -0.44 | -0.2 | -0.31 | -0.29 | -0.5 | -0.44 | n/a |
| PS Ratio | 6.80 | 8.10 | 8.92 | 16.22 | 31.08 | 23.30 | 42.03 | 753.82 | 20.93K | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 14.92 | 12.77 | 9.19 | 6.18 | 7.30 | 3.70 | 3.55 | 5.13 | 5.87 | 7.77 | 6.82 | 24.50 | 11.55 | 91.55 |
| P/FCF Ratio | -9.03 | -6.74 | -6.15 | -13.84 | -47.82 | -6.53 | -7.35 | -7.67 | -16.26 | -37.2 | -26.97 | -38.85 | -71.67 | -152.9 |
| P/OCF Ratio | -9.2 | -7.41 | -8.51 | -16.83 | -63.7 | -7 | -7.45 | -7.76 | -17.29 | -38.94 | -28.27 | -39.35 | -77.93 | -167.28 |
| OCF/S Ratio | -0.74 | -1.09 | -1.05 | -0.96 | -0.49 | -3.33 | -5.64 | -97.18 | -1.21K | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.04 | 0.16 | 0.09 | 0.05 | 0.04 | 0.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 2.24 | 2.49 | 3.28 | 4.63 | 6.76 | 8.13 | 6.90 | 3.43 | 8.27 | 16.13 | 14.98 | 9.33 | 27.12 | 10.96 |
| Current Ratio | 2.37 | 2.61 | 3.38 | 4.72 | 6.83 | 8.24 | 6.99 | 3.44 | 8.27 | 16.13 | 14.98 | 9.33 | 27.12 | 10.96 |
| Asset Turnover | 0.37 | 0.29 | 0.24 | 0.23 | 0.15 | 0.09 | 0.07 | 0.01 | 0.00 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -8.5 | -8.62 | -15.09 | -12.97 | -9.92 | -373.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.3 |
| Return on Equity | -2.23 | -2.2 | -2.01 | -0.49 | -0.16 | -0.62 | -0.32 | -0.79 | -0.52 | -0.27 | -0.32 | -0.7 | -0.19 | -0.64 |
| Return on Assets | -0.38 | -0.41 | -0.46 | -0.3 | -0.11 | -0.35 | -0.27 | -0.62 | -0.45 | -0.26 | -0.3 | -0.59 | -0.18 | -0.56 |
| Return on Invested Capital | -0.46 | -0.46 | -0.5 | -0.28 | -0.21 | -0.41 | -0.58 | -0.74 | -0.52 | -0.27 | -0.3 | -0.55 | -0.18 | -0.61 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.07 | n/a | n/a | n/a |
| Gross Profit Margin | 0.86 | 0.90 | 0.92 | 0.95 | 0.98 | 0.91 | 0.98 | 1.00 | -1.38K | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -1.02 | -1.4 | -1.95 | -1.29 | -0.69 | -3.88 | -3.84 | -115.67 | -1.85K | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -1.01 | -1.4 | -1.93 | -1.29 | -0.68 | -3.85 | -3.83 | -121.88 | -1.85K | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -0.96 | -1.31 | -1.79 | -1.09 | -1.22 | -4.09 | -7.21 | -125.93 | -1.86K | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -75.27 | -120.11 | -144.93 | -117.18 | -64.98 | -356.96 | -572.18 | -9.83K | -128.69K | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -0.84 | -1.19 | -1.76 | -1.17 | -0.52 | -3.76 | -3.45 | -119.65 | -1.84K | n/a | n/a | n/a | n/a | n/a |